In contrast, in the COVID-19-convalescent cohorts the percentages of individuals with strong IFN-γ response (> 4x103 mIU/ml) before third vaccination ranged between 31 and 42%, and reached between 50 and 62% after third vaccination (Figure 5A). This evidence concerns the gene IFNG and COVID-19.